Cambridge Scientific's bone screw gets FDA 'yes':
This article was originally published in Clinica
The US FDA has given 510(k) clearance for Cambridge Scientific's orthopaedic WISORB Malleolar bio-absorbable Screw for use in internal fixation of fractures with minimal displacement, such as in the ankle and foot. The partially threaded screw is composed of a bio-absorbable polymer matrix complexed with osteoconductive hydroxyapatite, which promotes bone growth while becoming absorbed as the body heals naturally, says the Cambridge, Massachusetts firm. Data from preclinical studies revealed no implant-related complications for the device, which may also be suitable for treating distal radial fractures, the firm adds.
You may also be interested in...
ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.